Apyx Medical Corporation
$3.94
▲
1.38%
2026-04-21 05:21:01
apyxmedical.com
NMS: APYX
Explore Apyx Medical Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$166.48 M
Current Price
$3.94
52W High / Low
$4.5 / $0.83
Stock P/E
—
Book Value
$0.35
Dividend Yield
—
ROCE
-11.69%
ROE
-76.15%
Face Value
—
EPS
$-0.27
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
205
Beta
1.54
Debt / Equity
265.25
Current Ratio
5
Quick Ratio
4.26
Forward P/E
-14.04
Price / Sales
3.13
Enterprise Value
$173.53 M
EV / EBITDA
-29.97
EV / Revenue
3.28
Rating
None
Target Price
$6.4
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Tactile Systems Technology, Inc. | $25.52 | 30.42 | $580.59 M | — | 12.57% | 8.77% | $37.77 / $8.61 | $9.76 |
| 2. | STERIS plc | $223.73 | 31.17 | $21.95 B | 1.11% | 10.53% | 10.47% | $269.44 / $209.98 | $72.93 |
| 3. | Smith & Nephew plc | $32.71 | 22.84 | $14.01 B | 2.29% | 9.67% | 11.84% | $1,441.5 / $960.8 | $6.22 |
| 4. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 5. | Spectral AI, Inc. | $1.89 | — | $60.15 M | — | -1104.36% | 116.67% | $3.21 / $1.13 | $-0.19 |
| 6. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 7. | Neuronetics, Inc. | $1.58 | — | $109.46 M | — | -28.31% | -1.35% | $4.85 / $0.8 | $0.32 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 19.16 M | 12.88 M | 11.37 M | 9.43 M | 14.22 M | — |
| Operating Profit | 0.01 M | -0.83 M | -2.57 M | -3.05 M | -3.05 M | — |
| Net Profit | -1.3 M | -1.98 M | -3.78 M | -4.15 M | -4.63 M | — |
| EPS in Rs | -0.03 | -0.05 | -0.09 | -0.1 | -0.11 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 52.84 M | 48.1 M | 52.35 M | 44.51 M |
| Operating Profit | -6.45 M | -18.84 M | -19.95 M | -23.56 M |
| Net Profit | -11.21 M | -23.46 M | -18.71 M | -23.18 M |
| EPS in Rs | -0.27 | -0.56 | -0.45 | -0.55 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 66.84 M | 64.84 M | 79.24 M | 51.77 M |
| Total Liabilities | 52.01 M | 50.51 M | 52.32 M | 13.98 M |
| Equity | 14.54 M | 14.21 M | 26.7 M | 37.58 M |
| Current Assets | 58.47 M | 56.44 M | 70.36 M | 42.97 M |
| Current Liabilities | 11.7 M | 10.72 M | 12.74 M | 11.85 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -8 M | -18.05 M | -5.25 M | -20.28 M |
| Investing CF | -1.11 M | -0.72 M | 6.73 M | -1.01 M |
| Financing CF | 9.58 M | 6.75 M | 32.17 M | 0.22 M |
| Free CF | -9.12 M | -18.77 M | -5.78 M | -21.29 M |
| Capex | -1.11 M | -0.72 M | -0.53 M | -1.01 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 9.86% | -8.11% | 17.61% | — |
| Earnings Growth % | 52.22% | -25.38% | 19.28% | — |
| Profit Margin % | -21.22% | -48.78% | -35.75% | -52.09% |
| Operating Margin % | -12.2% | -39.18% | -38.11% | -52.94% |
| Gross Margin % | 62.53% | 61.04% | 64.49% | 65.45% |
| EBITDA Margin % | -8.69% | -34.93% | -34.6% | -49.44% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.